top of page
Search


Top 5 Pain Points in Marketing Budget Allocation (and How to Fix Them)
Marketers have more performance data than ever, yet trust in that data isn’t really improving. The fix lies in performance measurement using Marketing Mix Modeling.
chien-pingwu
4 days ago7 min read
Â


Why Causality-Enabled Responsible AI Is the New Imperative for Financial Institutions
AI is redefining finance, but trust remains its currency. As AI systems make increasingly high-stakes decisions—who gets a loan, who’s flagged for AML, who receives an offer—the cost of error multiplies.
The message for financial leaders is clear:
A black-box AIÂ might optimize for accuracy but can expose the bank to unseen bias, regulatory penalties, or wasted budgets.
A Responsible AIÂ framework builds resilience, customer confidence, and long-term value.
Steven Ho
Oct 234 min read
Â


Beyond Correlation: Apotek’s Causal Path Platform for Smarter Target Identification in Drug Discovery
Author: Chin-Lin Chen, Ph.D / Data Scientist at Vizuro Key Takeaway Drug discovery has entered the era of big data. Every year, thousands of disease and normal samples are profiled — yet one critical bottleneck remains: identifying clinically meaningful target–marker gene pairs for new drug development . The core value of Apotek Path is for this purpose: Identify disease-relevant targets → Causal modeling reveals mechanistic gene interactions tailored to your disease contex
Chin-Lin Chen
Sep 265 min read
Â


From Correlation to Causation: Why Pharma Is Embracing Causal AI
Why causal AI is becoming pharma’s next strategic differentiator — from target validation to clinical trials and real-world evidence. Visualizing the Ladder of Causation in Pharma: from seeing correlations, to doing interventions, to imagining counterfactuals — the foundation of causal AI in drug discovery. Introduction: The Limits of Correlation in Drug Discovery Drug discovery today generates unprecedented volumes of data. Omics, imaging, electronic health records, and real
Esther Chen
Sep 76 min read
Â


Why Ad Platform Reports Don’t Tell the Full ROI Story
Ad platform reports from Google, Meta, and others usually over-credit the last click and don’t reveal the true drivers of ROI....
Po-Han Huang
Sep 13 min read
Â


Causal Disease Management – Explainable Risk Modeling and Intervention for Diabetes
Empowering Clinicians and General Populations with Actionable Insights Diabetes is one of the world’s fastest-growing health crises,...

Yu-Feng Wei
Mar 253 min read
Â


Google Meridian vs. Vizuro Kairos: the Pursuit for Optimal Omnichannel Marketing
Authors: Drs. Hung-Ken Chien and Yu-Feng Wei, Co-Founders of Vizuro Introduction In the ever-evolving pursuit to measure promotional effectiveness, marketing mix modeling (MMM) has long been the norm to assess campaign lifts and help allocate their spending. However, the emergence of omnichannel marketing in recent years has imposed a great challenge to the conventional MMM methodology, due to its requirements for high tactic mix and segment granularity. Coincidentally, both

Yu-Feng Wei
Feb 124 min read
Â


Vizuro Champions a New Era in AI Marketing Through Strategic Alliance with iKala
Expanding Global Reach with Kolr's Rebranding and Cutting-Edge AI Technologies (Left to right) Vizuro Co-founder and CEO, Yu-Feng Wei;...

Yu-Feng Wei
Jan 152 min read
Â


What’s next for drug discovery after AI won the 2024 Nobel Prize in Chemistry?
Key Takeaways: The 2024 Nobel Prize in Chemistry was awarded for groundbreaking advancements in computational protein structure...

Yu-Feng Wei
Oct 22, 20244 min read
Â
bottom of page